Akademik Veri Yönetim Sistemi
TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.35, sa.5, ss.398-407, 2024 (SCI-Expanded, Scopus, TRDizin)
Background/Aims: The percutaneous route is accepted as the most convenient course in the management of hydatid cysts (HCs). The aim of this study is to analyze the efficacy of the & Ouml;rmeci technique used in the treatment of hydatid cysts. Materials and Methods: This is a retrospective cohort study. Patients with HCs who presented to the Ankara University Faculty of Medicine, Department of Gastroenterology since 1991 were included. Patients with World Health Organization cystic echinococcosis (WHO -CE) types 1, 2, 3A -3B live cysts who were treated percutaneously at least once and followed up after a minimum of 6 months were analyzed. Results: A total of 1556 cystic lesions in 1035 patients have been presented to our department since 1991. Five hundred forty-four live HCs in 479 patients were treated with the & Ouml;rmeci technique. The mean follow-up time was 59.29 months for females and 57.18 for males. The overall clinical success rate of all treated cysts with the & Ouml;rmeci technique was 94.5%. After the treatment, a statistically significant decrease was found in all WHO -CE cyst types in terms of cyst sizes (P < .001 for all). Mortality, abscess and fistula formation, sclerosing cholangitis, and drug toxicities were not detected. Only 2 patients experienced reversible anaphylaxis during the treatment among 544 cysts (0.36%). Conclusion: Hydatid cysts can be treated percutaneously by the & Ouml;rmeci technique with a high success rate for WHO -CE type 1, 2, and 3B. The & Ouml;rmeci technique is an economic, simple, cheap, and repeatable outpatient procedure. It can be chosen as the first -line therapeutic modality in suitable patients with HCs.